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PhD studentships in Chemical Biology
Chemical Biology is a major theme of the Astbury Centre, and PhD studentships are available in chemical biology. Three-and four-year BBSRC-funded studentships are available which, for UK applicants, cover fees and a stipend (at least £12 900 pa this year).
The University of Leeds hosts the only taught MSc degree in Chemical Biology in the UK.
The course, founded in 2004, has a minimum entry requirement is an Upper Second class degree in Chemistry, Biochemistry or a related subject or equivalent. Around half of the graduating students have moved onto a PhD degree in Chemical Biology or a closely related discipline at a major centre for biomolecular science.
Teaching is delivered by chemical biologists from the School of Chemistry and from elsewhere within the Astbury Centre. Each student undertakes a major interdisciplinary research project involving a pair of supervisors with complementary expertise. In addition, an "Emerging Topics" module introduces the students to ten current topics in chemical biology which are delivered by academic and industrial lecturers.
Research infrastructure at the University of Leeds has been hugely expanded and enhanced through capital investment. A £7.5M Wellcome Trust-funded JIF bid was secured by the Astbury Centre which provided excellent facilities for chemical biology. 
Overcoming the Challenges of Multi-Target Drug Discovery
Drugs that act at more than one target can provide a more effective way of treating complex diseases than the use of target-selective agents. This one-day conference will highlight the relevance of this field to drug discovery, include some successful dual ligand case histories, the lessons learned from past projects and will look into the crystal ball to predict how this field may develop in the years ahead. Venue: University of York, United Kingdom FD139 is organised by the RSC Faraday Division. So many of the key molecules in biological systems are polymers: proteins, polysaccharides and the nucleic acids. Their long chain behaviour is a crucial contributing factor to their function in living systems. The fundamental motif of cells -membranes that separate space into multicompartments -has an analogy with polymeric amphiphiles, their slow dynamics allowing access to both kinetic insights and tougher membranes
The Science The meeting will aim to focus on two main strands: the physical chemistry of macromolecules as common ground between biology and polymer science; and the problems associated with biocompatibility and biodegradability of polymers, particularly with regard to their role as therapeutic delivery vehicles. Natural products continue to play a key role in drug discovery and provide challenges for synthetic chemistry. The organisers of "Drugs from Natural Products IV" invite you to join them in a 2 day meeting which will display examples of both these challenges and of the important role these agents play in the search for new medicines. A world class group of speakers from both academia & industry have agreed to present their work. Organised by the Royal Society of Chemistry and sponsored by the BBSRC and the EPSRC, the conference aims to play a leading role in bringing together the various communities that will drive forward tomorrow's bioscience research.
It is organised into four related themes, all of which are burgeoning multidisciplinary areas in which researchers from a range of disciplines play important roles and where exciting opportunities for chemists exist. "Molecules and Medicine" is a new succinct textbook with elements of both, medicinal chemistry and pharmacology. It comprises a preface, six main parts, a glossary and an (alphabetical) index on ca. 250 pages in total. Roughly a tenth of its scale (part I of VI) is dedicated to an introduction explaining basic concepts of biologically relevant chemistry. Pharmacological digressions interspersed among parts II-VI of the book supplement the reader's background on drug group related medical core topics (e.g. the metabolic syndrome). One double page at the end of part II is dedicated to receptor signalling. The drug descriptive parts (II-VI) consist of usually one paged monographs, classified by indication and followed by references for each drug, citing up to ten publications and the Protein Data Base code of any crystal structures available. Each monograph is titled with the INN name (and in brackets the original commercial name of the respective drug) and pictured by the structural formula, ball and stick formula and a space filling model. The space filling models finally raise awareness of the spatial requirements of drug molecules after decades of showing only two dimensional formulas in the majority of textbooks. The illustrations are followed by a brief profile listing the year of discovery, the year of introduction (plus pharmaceutical company involved), the drug category, the drug's main uses, other brand names (if applicable) and related drugs (if applicable).
The story of the drug's discovery or interesting epidemiological facts then embed a chemical description of the mechanism of action, often illustrated with active site models or biochemical reaction schemes. Verbal comments on kinetics or biopharmaceutical parameters (such as bioavailability, half life, distribution, accumulation) accomplish most of the monographs. On its back cover "Molecules and Medicine" addresses students, professionals and researchers in life sciences, chemistry and medicine as well as "educated lays". This book is suitable for patient-oriented-working health professionals, people in medical training and others who wish to learn more about the chemistry behind medicines without delving into a voluminous medicinal chemistry textbook, where drug molecules are usually presented alongside their synthesis and reactivity. "Molecules and Medicine" will be welcomed by people working in drug related-or biological sciences as a reference guide. Also scientists with a chemistry background will find it easy to access biological and pharmacological topics with this rather chemically oriented book. With its references to the Protein Data Base entries of the drug's targets, it could also be advantageous for people who aim to work in computer aided molecular design. Undergraduate students will appreciate this book as a compact revision supplement, not only because the introduction is excellent for all who wish to refresh their biologically relevant chemistry knowledge. "Molecules and Medicine" presents a well composed selection of drugs for those with training in natural sciences who wish to obtain a quick overview on today's mainly used drugs.
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